Monitoring lymphatic filariasis control in Tanzania: Effect of repeated mass drug administration on circulating filarial antigen prevalence in young schoolchildren

International Health

Volumn 3, Issue 3, 2011, Pages 182-187

  Simonsen, Paul E ^a   Magesa, Stephen M ^b,d   Derua, Yahya A ^b   Rwegoshora, Rwehumbiza T ^b   Malecela, Mwelecele N ^c   Pedersen, Erling M ^a  

^a DANISH BILHARZIASIS LABORATORY   (Denmark)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^d RTI INTERNATIONAL   (United States)

Author keywords

Children; Circulating filarial antigens; Control monitoring; Lymphatic filariasis; Mass drug administration; Tanzania

Indexed keywords

ALBENDAZOLE; IVERMECTIN; PARASITE ANTIGEN;

ARTICLE; CHILD; FEMALE; HUMAN; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; PARASITE CONTROL; PARASITE TRANSMISSION; PRIORITY JOURNAL; SCHOOL CHILD; TANZANIA; TREATMENT OUTCOME;

EID: 80052466585     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1016/j.inhe.2011.06.009     Document Type: Article

References (21)

1. Simonsen P.E. Filariases. Manson's Tropical Diseases 2009, 1477-1513. Saunders Elsevier Limited, London. 22nd ed. G.C. Cook, A.I. Zumla (Eds.).
2. Gyapong J.O., Kumaraswami V., Biswas G., Ottesen E.A. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 2005, 6:179-200.
3. Ottesen E.A. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 2006, 61:395-441.
4. Bockarie M.J., Taylor M.J., Gyapong J.O. Current practices in the management of lymphatic filariasis. Expert Rev Anti Infect Ther 2009, 7:595-605.
5. Malecela M.N., Lazarus W.M., Mwingira U., Mwakitalu E., Makene L., Kabali C., et al. Eliminating lymphatic filariasis: a progress report from Tanzania. J Lymphoedema 2009, 4:10-12.
6. Simonsen P.E., Pedersen E.M., Rwegoshora R.T., Malecela M.N., Derua Y.A., Magesa S.M. Monitoring lymphatic filariasis control in Tanzania: Effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission. PLoS NTD 2010, 4:e696.
7. Pedersen E.M., Stolk W.A., Laney S.J., Michael E. The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic Filariasis. Trends Parasitol 2009, 25:319-327.
8. Weil G.J., Lammie P.J., Weiss N. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 1997, 13:401-404.
9. Weil G.J., Ramzy M.R. Diagnostic tools for filariasis elimination programs. Trends Parasitol 2007, 23:78-82.
10. Rwegoshora R.T., Pedersen E.M., Mukoko D.A., Meyrowitsch D.W., Masese N., Malecela-Lazaro M.N., et al. Bancroftian filariasis: patterns of vector abundance and transmission in two East African communities with different levels of endemicity. Ann Trop Med Parasitol 2005, 99:253-265.
11. Lammie P.J., Hightower A.E., Eberhard M.L. Age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. Am J Trop Med Hyg 1994, 51:348-355.
12. Simonsen P.E., Lemnge M.M., Msangeni H.A., Jakobsen P.H., Bygbjerg I.C. Bancroftian filariasis: the patterns of filarial-specific immunoglobulin G1 (IgG1), IgG4, and circulating antigens in an endemic community of northeastern Tanzania. Am J Trop Med Hyg 1996, 55:69-75.
13. Simonsen P.E., Meyrowitsch D.W., Jaoko W.G., Malecela M.N., Mukoko D., Pedersen E.M., et al. Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in East Africa. Am J Trop Med Hyg 2002, 66:550-559.
14. Witt C., Ottesen E.A. Lymphatic filariasis: an infection of childhood. Trop Med Int Health 2001, 6:582-606.
15. Beau de Rochars M.V.E., Milord M.D., St.Jean Y., Desormeaux A.M., Dorvil J.J., Lafontant J.G., et al. Geographical distribution of lymphatic filariasis in Haiti. Am J Trop Med Hyg 2004, 71:598-601.
16. Onapa A.W., Simonsen P.E., Baehr I., Pedersen E.M. Rapid assessment of the geographical distribution of lymphatic filariasis in Uganda, by screening of schoolchildren for circulating filarial antigens. Ann Trop Med Parasitol 2005, 99:141-153.
17. WHO. Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. Geneva: World Health Organization; 2005. WHO/CDS/CPE/CEE/2005.50.
18. Simonsen P.E., Magesa S.M., Dunyo S.K., Malecela-Lazaro M.N., Michael E. The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania. Trans R Soc Trop Med Hyg 2004, 98:462-472.
19. Weil G.J., Kastens W., Susapu M., Laney S.J., Williams S.A., King C.L., et al. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. PLoS NTD 2008, 2:e244.
20. El-Setouhy M., Elaziz K.M.A., Helmy H., Farid H.A., Kamal H.A., Ramzy R.M.R., et al. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg 2007, 77:1069-1073.
21. Boyd A., Won K.Y., McClintock S.K., Donovan C.V., Laney S.J., Williams S.A., et al. A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti. PLOS NTD 2010, 4:e640.